Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of December 14, 2025

By / December 14, 2025

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

POMALYST (pomalidomide)

Bristol Patent: 8,198,262 Expiration: Dec 17, 2025

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

Drug APIs Start Here: How to Nail Your KSM Strategy
The Uncoupling of Device and Drug: A Strategic…
The Art of the Second Act: A Six-Step Framework for…
The Patent Cliff's Shadow: Impact on Branded…
The Patent Playbook for Pharma: Protect Your Drug.…
The Global Patent Thicket: A Comparative Analysis of…
The Patent Cliff Protocol: Advanced Methodologies…
More Biopharmaceutical Competition, Better Products:…
The Missing Ingredient: Why Patent Data Is the Key…
The Crystal Ball of Pharma: Using Patent Expiry Data…
Effective Drug Patent Prosecution Strategies:…
When should you outsource drug development: A…
Drug Repositioning: One Molecule. Two Indications.…
The 92-Day Pill Puzzle: Why Your 3-Month Supply…
How to own a Market you Don't Own: Market Access…
A Framework for Multi-Year Pharmaceutical Patent…
The Patent-Powered Pitch: A Founder's Guide to…
The Innovator's Compass: Navigating the Patent…
The Patent Cliff Playbook: Transforming Drug Patent…
Navigating the Patent Maze: A CDMO's Guide to IP…
The Patent Playbook Your Lawyers Won’t Write: Patent…
The Pharmaceutical Patent Playbook: Forging…
Beyond the Prescription Pad: Why Patent Intelligence…
AI-Driven Strategies: Pharma's Answer to Patent Expirations

The Erosion of the Safe Harbor: How “Skinny Labels” Became a Multi-Billion Dollar Liability Minefield

The Iceberg Illusion: Why Tracking Drug Expiry Dates Is the Least Important Part of Patent Risk

Related Posts

Drug Patent Expirations for the Week of August 10, 2025

Patent Expiration / By

Drug Patent Expirations for the Week of August 17, 2025

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

The Generic’s Gauntlet: A Strategic Playbook for ANDA Filing and Market Domination
From Chaos to Calculation: A Comprehensive Report on Algorithmic Drug Portfolio Optimization
The AI Revolution in Drug Repurposing: A Comprehensive Pipeline Analysis from Target Identification to Clinical and Commercial Validation
How Financial Analysts Use Drug Patent Expiry Data to Predict Pharma Stock Movements
The Myth of the “Clean” Patent Expiry in Pharmaceuticals: Strategic Analysis of Loss of Exclusivity, Patent Thickets, and Market Entry Dynamics

Popular Posts

The Pharmaceutical Gambit: An Analysis of Why India Lags China and a Roadmap to Competitive Parity
Valuation of Pharmaceutical Companies: A Comprehensive Analysis of Key Considerations
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
The AI Revolution in Drug Repurposing: A Comprehensive Pipeline Analysis from Target Identification to Clinical and Commercial Validation
Top 6 issues facing the biotechnology industry
PBMs, Formularies, and Rebates: What Investors Should Know
The New Pharma Playbook: A 2025-2030 Guide to Market Domination in a Data-Driven World
How Long Does a Patent Last for Drugs? A Comprehensive Guide to Pharmaceutical Patent Duration
Comprehensive Guide to Pharmaceutical Portfolio Management: Essential Reading Resources
The Rise of Telehealth Companies Like Ro and Hims & Hers: How Direct-to-Consumer Telehealth Redefined the Pharmaceutical Value Chain

Copyright © 2025 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested

Last Updated on December 14, 2025 by